Abstract
Background: Various mechanisms have been proposed to explain the association between plasma total homocysteine (tHcy) and risk of cardiovascular disease, including oxidative activity of homocysteine.
Objective: To explore the putative role of reactive oxygen species in the association between plasma tHcy and risk of cardiovascular disease in healthy individuals.
Design: A double-blind, placebo-controlled crossover intervention to increase folate intake through diet (increased consumption of folate-rich foods) and supplement (400 µg folic acid) was carried out in 126 healthy men and women. Measurements were made of antioxidant activity in red blood cells and plasma, and products of oxidant damage in plasma.
Results: Diet and supplement-based interventions led to an increase in measures of folate status and a reduction in plasma tHcy. This was not associated with any significant change in measures of antioxidant activity (plasma and red blood cell glutathione peroxidase activity and red blood cell superoxide dismutase activity) or oxidant damage (plasma malondialdehyde), although an improvement in plasma total antioxidant capacity just failed to reach significance.
Conclusions: In healthy individuals lowering plasma tHcy does not have any functional implications regarding oxidative damage.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Andersson, A, Isakson, A, Brattstrom, L & Hultberg, B (1993). Homocysteine and other thiols determined in plasma by HPLC and thiol-specific postcolumn derivatization. Clin. Chem., 39, 1590–1597.
Ashfield-Watt, PAL, Pullin, C, Whiting, J, Clark, ZE, Moat, SJ, Burr, ML, Lewis, MJ, Powers, HJ & McDowell, IFW (2002). Methylene tetrahydrofolate reductase (C677T) genotype modulates blood folate and homocysteine responses to a folate rich diet or low dose folate supplement: a randomised controlled trial. Am. J. Clin. Nutr., 76, 180–186.
Bellamy, MF & McDowell, IFW (1997). Putative mechanisms for vascular damage by homocysteine. J. Inher. Metab. Dis., 20, 307–315.
Blom, HJ, Kleinveld, HA, Boers, GHJ, Demacker, PNM, Hak-Lemmers, HLM, Te Poele-Pothoff, MTWB & Trijbels, JMF (1995). Lipid peroxidation and susceptibility of low-density lipoprotein to in vitro oxidation in hyperhomocysteinaemia. Eur. J. Clin. Invest., 25, 149–154.
Blundell, G, Goodman Jones, B, Rose, FA & Tudball, N (1996). Homocysteine mediated endothelial cell toxicity and its amelioration. Atherosclerosis, 122, 163–172.
Bonham, JR, Moat, SJ, Bones, CH, McDowell, IFW, Lewis, MJ & Powers, HJ (2000). Oral ascorbic acid ameliorates homocysteine-mediated endothelial dysfunction in classical homocystinuria both acutely and chronically. J. Inher. Metab. Dis., 23, (Suppl) 65
Bostom, AG, Rosenberg, IH, Lindenmens, J, Hofmasn, A & Grobbee, DE (1997). Homocysteine, atherosclerosis and prevalent cardiovascular disease in the elderly. The Rotterdam Study. J. Intern. Med., 242, 339–347.
Boushey, CJ, Beresford, SA, Omenn, GS & Motulsky, AG (1995). A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA, 274, 1049–1057.
Chambers, JC, McGregor, A, Jean-Marie, J, Obeid, OA & Kooner, JS (1999). Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinaemia: an effect reversible with vitamin C therapy. Circulation, 99, 1156–1160.
Clark, ZE, Bowen, DJ, Whately, SD, Bellamy, MF, Collins, PW & McDowell, IFW (1998). Genotyping method for methylenetetrahydrofolate (C677T thermolabile variant) using heteroduplex technology. Clin. Chem, 44, 2360–2362.
Clarke, R, Naughten, E, Cahalane, S, O'Sullivan, K, Mathias, P, McCall, T & Graham, I (1992). The role of free radicals as mediators of endothelial cell injury in hyperhomocysteinaemia. Irish J. Med. Sci., 161, 561–564.
Crosby, W & Houchin, DN (1957). Preparing standard solutions of cyanmethaemoglobin. Blood, 12, 1132–1136.
Donnelly, JG & Pronovost, C (2000). Evaluation of the Abott IMX fluorescence polarization immunoassay: comparison with high performance liquid chromatography. Ann. Clin. Biochem., 37, 194–198.
Halvorsen, B, Brude, I, Drevon, CA, Nysom, J, Ose, L, Christianson, EN & Nenseter, MS (1996). Effects of homocysteine on copper ion-catalysed, azo-compound initiated, and mononuclear cell-mediated modification of low density lipoprotein. J. Lipid Res., 37, 1591–1600.
Hirano, K, Ogihara, T, Miki, M, Yasuda, H, Tamai, H, Kawamura, N & Mino, M (1994). Homocysteine induces iron-catalysed peroxidation of low-density lipoprotein that is prevented by alpha-tocopherol. Free Rad. Res., 21, 267–276.
Homocysteine Lowering Trialists Collaboration (1998). Lowering blood homocysteine with folic acid supplements: meta-analysis of randomised trials. Br. Med. J., 316, 894–898.
Jacques, P, Selhub, J, Bostom, AG, Wilson, PWF & Rosenberg, IH (1999). The effect of fortification on plasma folate and total homocysteine concentrations. New Engl. J. Med., 34, 1449–1454.
Kanani, PM, Sinkey, CA, Browning, RL, Allaman, M, Knapp, HR & Haynes, WG (1999). Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inaemia in humans. Circulation, 100, 1161–1168.
Lang, D, Kredan, M, Moat, SJ, Hussain, SA, Powell, CA, Bellamy, MF, Powers, HJ & Lewis, MJ (2000). Homocysteine-induced inhibition of endothelium-dependent relaxation in the rabbit aorta: a role for superoxide anions. Arterioscler. Thromb. Vasc. Biol., 20, 422–427.
Loehrer, FMT, Haefelli, WE, Angst, CP, Browne, G, Frick, G & Fowler, B (1996). Effect of methionine loading on 5-methyltetrahydrofolate, S-adenosylmethionine and S-adenosylhomocysteine in plasma of healthy humans. Clin. Sci., 91, 79–86.
Marklund, S & Marklund, G (1974). The involvement of the superoxide anion radical in the autooxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur. J. Biochem., 47, 469–474.
Miller, NJ, Rice-Evans, C, Davies, MJ, Gopinathan, V & Milner, A (1993). A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin. Sci., 84, 407–412.
Moat, SJ, Bonham, JR, Tanner, MS, Allen, JC & Powers, HJ (1999). Recommended approaches for the laboratory diagnosis and monitoring of patients with hyperhomocysteinaemia. Ann. Clin. Biochem., 36, 372–379.
Moat, SJ, Bonham, JR, Cragg, RA & Powers, HJ (2000). Elevated plasma homocysteine elicits an increase in antioxidant enzme activity. Free Rad. Res., 33, 171–179.
Moat, SJ, Bonham, JR & Powers, HJ (2001). The role of plasma aminothiols as a component of the plasma antioxidant defence system and its relevance to homocysteine-mediated vascular disease. Clin. Sci., 100, 73–79.
Mudd, SH, Levy, HL & Skovby, F (1995). Disorders of Transsulphuration. The Metabolic and Molecular Basis of Inherited Disease, 7th ed., ed. CR Scriver pp1279–1327, New York: McGraw-Hill
Nakano, E (2000). The effect of homocysteine on the oxidation of low density lipoproteins. Medical Science Thesis, University of Sheffield
Nakano, E, Higgins, JA & Powers, HJ (2002). Folate protects against oxidative modification of human low density lipoproteins. Br. J. Nutr., (in press)
Nielson, F, Mikkelsen, BB, Nielson, JB, Andersen, HR & Grandjean, P (1997). Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors. Clin. Chem., 43, 1209–1214.
Paglia, DE & Valentine, WN (1967). Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med., 70, 158–169.
Pullin, CH, Ashfield-Watt, PAL, Burr, ML, Clark, ZE, Lewis, MJ, Moat, SJ, Newcombe, RG, Powers, HJ, Whiting, JM & McDowell, IFW (2001). Optimisation of dietary folate or low dose folic acid supplements lower homocysteine but do not enhance endothelial function in healthy adults irrespective of methylene tetrahydrofolate reductase (C677T) genotype. J. Am. Coll. Cardiol., 38, 1799–1805.
Starkebaum, G & Harlan, JM (1986). Endolethial cell injury due to copper-catalysed hydrogen peroxide generation from homocysteine. J. Clin. Invest., 77, 1370–1376.
Thurnham, DI, Smith, E & Flora, PS (1988). Concurrent liquid chromatographic assay of retinol, tocopherol, carotene, lycopene and crytoxanthine in plasma with tocopherol acetates as internal standard. Clin. Chem., 34, 377–381.
Todesco, L, Angst, C, Litynski, P, Loehrer, F, Fowler, B & Haefeli, WE (1999). Methylenetetrahydrofolate reductase polymorphism, plasma homocysteine and age. Eur. J. Clin. Invest., 29, 1003–1009.
Usui, M, Matsuoka, H, Miyazaki, H, Ueda, S, Okuda, S & Imaizumi, T (1999). Endothelial dysfunction by acute hyperhomocysteinaemia: restoration by folic acid. Clin. Sci., 96, 235–239.
Verhaar, MC, Wever, RMF, Kastelein, JJP, van Dam, T, Koomans, HA & Rabelink, TJ (1998). 5-Methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolaemia. Circulation, 97, 237–241.
Verhoef, P, Stampfer, MJ, Buring, JE, Gaziano, JM, Allen, RH, Stabler, SP, Reynolds, RD, Kok, FJ, Hennekens, CH & Willett, WC (1996). Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12 and folate. Amer. J. Epidemiol., 143, 845–859.
Voutilainen, S, Morrow, JD, Roberts, LJ, Alfthan, G, Alo, H, Nyyssonen, K & Salonen, JT (1999). Enhanced in vivo lipid peroxidation in association with elevated plasma homocysteine levels. Arterioscler. Thromb. Vasc. Biol., 19, 1263–1266.
Vuilleumier, JP & Keck, E (1989). Fluorometric assay of vitamin C in biological materials using a centrifugal analyser with fluorescence attachment. Micron. Anal., 5, 25–34.
Wang, XL, Adachi, T, Sim, AS & Wilcken, DEL (1998). Plasma extracellular dismutase levels in an Australian population with coronary artery disease. Arterioscler. Thromb. Vasc. Biol., 18, 1915–1921.
Wayner, DDM, Burton, GW, Ingold, KU, Barclay, LRC & Locke, SJ (1987). The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma. Biochem. Biophys. Acta, 924, 408–419.
Wilcken, DE, Wang, XL, Adachi, T, Hara, H, Duarte, N, Green, K & Wilcken, B (2000). Relationship between homocysteine and superoxide dismutase in homocystinuria: possible relevance to cardiovascular risk. Arterioscler. Thromb. Vas. Biol., 20, 1199–1202.
Wilmink, HW, Stroes, ESG, Erkelens, WD, Gerritsen, WB, Wever, R, Banga, J-D & Rabelink, TJ (2000). Influence of folic acid on postprandial endothelial dysfunction. Arterioscler. Thromb. Vasc. Biol., 20, 185–188.
Acknowledgements
This study was supported by a project grant from the Food Standards Agency of the UK (ANO506 and N05006).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Moat, S., Hill, M., McDowell, I. et al. Reduction in plasma total homocysteine through increasing folate intake in healthy individuals is not associated with changes in measures of antioxidant activity or oxidant damage. Eur J Clin Nutr 57, 483–489 (2003). https://doi.org/10.1038/sj.ejcn.1601554
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ejcn.1601554
Keywords
This article is cited by
-
Methyl-donor depletion of head and neck cancer cells in vitro establishes a less aggressive tumour cell phenotype
European Journal of Nutrition (2018)